Clinical Trials Browser

Phase 1/2 × Head and Neck Squamous Cell Cancer × toripalimab × Clear all

NCT04856631 2022-12-19

A Study of Toripalimab Injection (JS001) + Cetuximab in Treatment of Advanced Head and Neck Squamous Cell Cancer

Phase 1/2 Unknown

Head and Neck Squamous Cell Cancer